InspireMD, Inc. Marketable Securities (Current)
InspireMD, Inc. (NSPR) had Marketable Securities (Current) of $15.27 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-14
- 2026-06-30: Marketable Securities, Current $15.27M.
- 2026-03-31: Marketable Securities, Current $30.21M.
- 2025-12-31: Marketable Securities, Current $45.27M.
- 2025-06-30: Marketable Securities, Current $7.87M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $15.27M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $30.21M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $45.27M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $7.87M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $13.70M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $15.72M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $24.58M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $18.78M 10-Q · filed 2025-08-04 |
| 2024-03-31 | $24.56M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $29.38M 10-K · filed 2026-03-18 |
| 2023-09-30 | $29.16M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $28.82M 10-Q · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |